SCOPUS 정보 검색 플랫폼

Lancet

Volumn 361, Issue 9365, 2003, Pages 1240-

Withdrawing drugs: Nefazodone, the start of the latest saga

(1) Edwards, I Ralph a

a UPPSALA MONITORING CENTRE (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDERMATOPHYTIC AGENT; ASTEMIZOLE; BENOXAPROFEN; CISAPRIDE; DIPYRONE; NEFAZODONE; PHENYLBUTAZONE; PHENYLPROPANOLAMINE; TERFENADINE;

COMPARATIVE STUDY; CONSUMER; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER INJURY; LIVER TOXICITY; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; UNITED KINGDOM; UNITED STATES;

EID: 0037433657 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(03)13030-9 Document Type: Note

Times cited : (15)

References (9)

1
- 0001217931
- Non-steroidal anti/inflammatory drugs
- M.N.G. Dukes, & J.K. Aronson. Amsterdam: Elsevier
- Biscarini L. Non-steroidal anti/inflammatory drugs. Dukes M.N.G., Aronson J.K. Meyler's side effects of drugs. 14th edn:2000;266-267 Elsevier, Amsterdam.
- (2000) Meyler's side effects of drugs 14th edn , pp. 266-267
- Biscarini, L.¹

2
- 85031209522
- March 6
- Public Citizen. Petition to the FDA to ban the antidepressant drug nefazadone (SERZONE) (HRG publication #1657). March 6, 2003: http://www.citizen.org/publications/release.cfm?ID=7233 (accessed March 31, 2003).
- (2003) Petition to the FDA to ban the antidepressant drug nefazadone (SERZONE) (HRG publication #1657)

3
- 85031205812
- March 6
- Public Citizen. Public Citizen calls on FDA to ban antidepressant Serzone. March 6, 2003: http://www.citizen.org/pressroom/release.cfm?ID=1351 (accessed March 31, 2003).
- (2003) Public Citizen calls on FDA to ban antidepressant Serzone

4
- 85101729864
- Pharmaceutical companies and the third world
- Sanjay A.P., Lakshmi P.K., Rao B.C., Sahni P. Pharmaceutical companies and the third world. Lancet. 361:2003;1136.
- (2003) Lancet , vol.361 , pp. 1136
- Sanjay, A.P.¹ Lakshmi, P.K.² Rao, B.C.³ Sahni, P.⁴

5
- 0037220149
- The science and politics of medicines control
- Abraham J. The science and politics of medicines control. Drug Saf. 26:2003;135-143.
- (2003) Drug Saf , vol.26 , pp. 135-143
- Abraham, J.¹

6
- 0035880320
- Liver enzyme monitoring in patients treated with troglitazone
- Graham D.J., Drinkard C.R., Shatin D., et al. Liver enzyme monitoring in patients treated with troglitazone. JAMA. 286:2001;831-833.
- (2001) JAMA , vol.286 , pp. 831-833
- Graham, D.J.¹ Drinkard, C.R.² Shatin, D.³

7
- 0034694849
- Contraindicated use of cisapride
- Smalley W., Shatin D., Wysowski D.K., et al. Contraindicated use of cisapride. JAMA. 284:2000;3036-3039.
- (2000) JAMA , vol.284 , pp. 3036-3039
- Smalley, W.¹ Shatin, D.² Wysowski, D.K.³

8
- 0030694227
- The challenge of effectively communicating risk-benefit information
- Edwards I.R., Hugman B. The challenge of effectively communicating risk-benefit information. Drug Saf. 17:1997;216-227.
- (1997) Drug Saf , vol.17 , pp. 216-227
- Edwards, I.R.¹ Hugman, B.²

9
- 0036913686
- Labelling and 'Dear Doctor' letters: Are they noncommittal?
- van Grootheest A.C.K., Edwards I.R. Labelling and 'Dear Doctor' letters: are they noncommittal? Drug Saf. 25:2002;1051-1055.
- (2002) Drug Saf , vol.25 , pp. 1051-1055
- Van Grootheest, A.C.K.¹ Edwards, I.R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.